Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-06 Sale |
2024-12-10 5:12 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
2,283 | $8.06 | $18,401 | 29,305 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-17 8:38 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
7,266 | $12.33 | $89,590 | 32,341 (Direct) |
View |
| 2023-12-05 Sale |
2023-12-06 8:29 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev |
2,125 | $9.63 | $20,464 | 37,260 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-14 4:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
7,500 | $0 | 33,479 (Direct) |
View |
| 2025-02-12 Tax Withholding |
2025-02-14 4:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
3,326 | $5.59 | 33,479 (Direct) |
View |
| 2024-12-01 Tax Withholding |
2024-12-03 6:37 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
753 | $8.6 | 31,588 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 5:06 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
81,000 | $0 | 81,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 8:21 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
3,320 | $0 | 39,607 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 8:21 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
973 | $12.41 | 39,607 (Direct) |
View |
| 2023-12-01 Tax Withholding |
2023-12-05 9:21 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev |
753 | $9.49 | 39,385 (Direct) |
View |
| 2023-11-22 Option Award |
2023-11-22 5:12 pm |
N/A 2033-11-22 |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev |
83,000 | $0 | 83,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 9:51 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
20,997 | $0 | 40,138 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 9:51 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
6,725 | $52.77 | 40,138 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 7:27 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
498 | $44.33 | 25,866 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:38 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
58,500 | $0 | 66,364 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 9:51 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
552 | $62.49 | 7,864 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-15 9:51 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
1,616 | $0 | 7,864 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 8:00 pm |
N/A 2031-11-19 |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
35,200 | $0 | 35,200 (Direct) |
View |
| 2020-12-07 Option Award |
2020-12-08 7:16 pm |
N/A 2030-12-07 |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
65,000 | $0 | 65,000 (Direct) |
View |